Company Filing History:
Years Active: 2017-2022
Title: Wes Sisson: Innovator in Cancer Treatment
Introduction
Wes Sisson is a notable inventor based in San Diego, CA, who has made significant contributions to the field of cancer treatment. With a focus on developing innovative therapies, he holds 2 patents that showcase his expertise and dedication to advancing medical science.
Latest Patents
Wes Sisson's latest patents include advancements in arginine deiminase (ADI) proteins. His inventions relate to isolated ADI proteins that exhibit reduced cross-reactivity with anti-ADI-PEG 20 antibodies compared to ADI-PEG 20. These proteins maintain functional characteristics that are comparable to or better than ADI-PEG 20. The compositions he developed aim to treat arginine-dependent diseases, including various forms of cancer.
Career Highlights
Throughout his career, Wes has worked with several companies, including Polaris Group and TDW Group. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.
Collaborations
Wes has collaborated with notable coworkers such as Richard E. Showalter and Robert Almassy. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Wes Sisson's innovative work in the development of cancer treatment therapies highlights his commitment to improving patient outcomes. His contributions to the field through his patents and collaborations demonstrate the importance of innovation in medical research.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.